Milestone Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$165M
Lead Investor(s):RTW Investments, LP

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Milestone Pharmaceuticals's estimated annual revenue is currently $7.1M per year.
  • Milestone Pharmaceuticals received $80.0M in venture funding in October 2018.
  • Milestone Pharmaceuticals's estimated revenue per employee is $155,000
  • Milestone Pharmaceuticals's total funding is $165M.

Employee Data

  • Milestone Pharmaceuticals has 46 Employees.
  • Milestone Pharmaceuticals grew their employee count by 70% last year.
  • Milestone Pharmaceuticals currently has 1 job openings.

Milestone Pharmaceuticals Inc. is a cardiovascular drug development company developing novel small molecule therapeutics for transient cardiovascular conditions. Milestone's lead product is a potent and short-acting nasally-delivered calcium channel antagonist for the episodic treatment of paroxysmal supraventricular tachycardia (PSVT). The company's lead product, etripamil (MSP-2017), is in phase 3.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power